U.S. Senator Jacky Rosen announced that 15 additional medications have been selected for Medicare drug pricing negotiations, ...
Trump has reversed some of President Biden’s initiatives, including $2 monthly out-of-pocket cap on some generics and ...
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...
As part of the Inflation Reduction Act, price negotiations with manufacturers will begin ... (CMS), announced that 15 new drugs that are currently covered under Medicare Part D will be selected for ...
The pharma expects a modest financial headwind this year from changes to Medicare prescription drug benefits under the ...
On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...
Despite online claims, President Donald Trump’s executive orders did not include removing Medicare’s $35 monthly out-of-pocket price cap, which is set by law.
The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...
New AARP Report Finds Medicare Part D Enrollees Who Reach the New $2,000 Out-of-Pocket Spending Cap Will Save Thousands ...
HHS adds 15 drugs to Medicare Part D price negotiations, targeting cost reductions under the Inflation Reduction Act. New ...
The talks around drugs including Novo Nordisk’s Wegovy, GSK’s Trelegy Ellipta, and Pfizer’s Xtandi will set Medicare prices ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback